What is the likely diagnosis and recommended initial management for a patient with markedly elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma‑glutamyl transferase (GGT) and mildly elevated alkaline phosphatase?

Likely Diagnosis and Initial Management

This patient most likely has alcoholic liver disease given the markedly elevated GGT (1152 U/L) disproportionate to the transaminases, with an AST/ALT ratio slightly greater than 1, and you should immediately obtain a detailed alcohol history, perform abdominal ultrasound, and initiate a comprehensive liver aetiology screen.

Pattern of Liver Injury

Your patient demonstrates a mixed hepatocellular-cholestatic pattern of injury 1:

• AST 230 U/L and ALT 226 U/L represent moderate elevations (5-10 times upper limit of normal, assuming ULN ~40 U/L) 1
• AST/ALT ratio of 1.02 is close to but does not exceed the threshold of 2 that strongly suggests alcoholic liver disease 1
• GGT 1152 U/L is markedly elevated and disproportionate to other enzymes, which is highly characteristic of alcohol-induced liver injury 1, 2
• Alkaline phosphatase 137 U/L is mildly elevated, suggesting some cholestatic component 1

The R value (ratio of ALT/ULN to ALP/ULN) would classify this as either mixed or hepatocellular pattern depending on your laboratory's reference ranges 1.

Most Likely Diagnosis: Alcoholic Liver Disease

The dramatically elevated GGT is the key diagnostic clue 1:

• GGT is elevated in approximately 75% of habitual drinkers 1
• While GGT can be elevated in non-alcoholic liver disease, obesity, diabetes, and smoking, a level exceeding 1000 U/L in the context of elevated transaminases strongly suggests alcohol as the primary etiology 1, 2
• The AST/ALT ratio approaching 2 further supports alcoholic etiology, though ratios >2 are more specific and ratios >3 are highly suggestive 1
• In alcoholic liver disease, AST and ALT typically do not exceed 300 IU/L, which fits this presentation 1

Differential Diagnoses to Exclude

While alcoholic liver disease is most likely, you must systematically exclude 1:

• Non-alcoholic fatty liver disease (NAFLD): AST/ALT ratio typically <1, though can overlap 1
• Drug-induced liver injury: Obtain complete medication history including over-the-counter drugs, herbals, and supplements 1, 3
• Viral hepatitis B and C: Can present with similar enzyme patterns 1
• Autoimmune hepatitis: Less likely with this pattern but must be excluded 1
• Hemochromatosis: Can coexist with other liver diseases 1
• Choledocholithiasis: Can rarely cause transaminase elevations >1000 U/L, but typically presents with higher alkaline phosphatase and bilirubin 4

Immediate Initial Management Steps

1. Detailed Alcohol History 1

Calculate average daily alcohol intake using: [amount consumed (mL) × alcohol by volume (%) × 0.785 × drinking days per week] ÷ 7 1

• Alcoholic liver disease threshold: >40 g/day in men, >20 g/day in women 1
• Obtain history from family members if patient underreports 1
• Document type of beverage, quantity, frequency, and duration 1

2. Standard Liver Aetiology Screen 1

Order the following tests immediately:

• Abdominal ultrasound to assess for steatosis, cirrhosis, and exclude biliary obstruction 1
• Hepatitis B surface antigen and hepatitis C antibody (with reflex HCV RNA if positive) 1
• Autoimmune markers: anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins 1
• Iron studies: simultaneous serum ferritin and transferrin saturation 1
• Additional baseline labs: albumin, total and direct bilirubin, prothrombin time/INR, complete blood count, mean corpuscular volume 1

3. Assess for Complications and Severity 1

Examine for:

• Signs of chronic liver disease: jaundice, spider angiomata, palmar erythema, ascites, peripheral edema, hepatic encephalopathy 1
• Portal hypertension: splenomegaly, thrombocytopenia, varices 1
• Extrahepatic manifestations: parotid enlargement, Dupuytren's contracture, peripheral neuropathy, cardiomyopathy 1

4. Risk Stratification

If alcoholic liver disease is confirmed:

• Assess synthetic function: albumin and INR indicate severity of liver dysfunction 1
• Platelet count: low or decreasing platelets suggest portal hypertension 1
• Consider fibrosis assessment: If NAFLD coexists, use FIB-4 or NAFLD Fibrosis Score for risk stratification 1

Critical Pitfalls to Avoid

• Do not assume isolated GGT elevation is benign: While isolated GGT elevation alone is insufficient to diagnose liver injury, when combined with elevated transaminases as in this case, it strongly suggests significant hepatocellular damage 1, 3
• Do not overlook drug-induced liver injury: Review ALL medications including acetaminophen, which can cause severe transaminase elevation in alcoholics even at therapeutic doses 1
• Do not miss biliary obstruction: Although less likely with this pattern, the mildly elevated alkaline phosphatase warrants ultrasound to exclude choledocholithiasis 4
• Do not forget metabolic syndrome: NAFLD frequently coexists with alcoholic liver disease, and both conditions may contribute to liver injury 1

When to Refer or Escalate

Refer to hepatology if 1:

• Transaminases remain elevated >6 months despite alcohol cessation
• Evidence of decompensated cirrhosis (ascites, encephalopathy, variceal bleeding)
• Abnormal synthetic function (low albumin, elevated INR)
• Diagnostic uncertainty after initial workup

The mortality rate in alcoholic hepatitis can reach 60%, making early identification and management critical 5.